2017 Country 2 Country 4 Cancer Ride
10,007 raised
92 contributors
46 Weeks running
Bristol-Myers Squibb is excited to announce the 2nd edition of the epic European Country 2 Country 4 Cancer ride, in support of the Union for International Cancer Control to accelerate the fight against cancer and for a better life for cancer patients.

About the 2017 Country 2 Country 4 Cancer Ride

After the great success of the first edition of the European Country 2 Country 4 Cancer ride in 2016, Bristol-Myers Squibb employees from across Europe will again ride over 3,600 km from Germany to the UK. Along the way, they will ride through Switzerland, Italy, France and Spain, all to raise funds for cancer research and organisations that support cancer patients in Europe. Each of the organisations benefiting are members of the Union for International Cancer Control.

In this 2nd edition of the ride starting on 8 September 2017 and lasting 18 days, 78 European Bristol-Myers Squibb team members will be riding in 6 different Country teams and each group will be performing a leg of the ride averaging 720 km in 3 days.

C2C4C ride map

Who are the riders

The participants are novice riders, who have committed themselves to 5 months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. All are dedicated Bristol-Myers Squibb employees who are riding to help raise funds to fight against cancer by supporting European cancer organisations, members of the Union for International Cancer Control.

The riders will be divided in the following 6 teams raising funds for different cancer organisations (see below).

Why raise funds for cancer organisations

Cancer is among the leading causes of death worldwide. Each year, there are 14 million new cases and 8.2 million cancer-related deaths worldwide, and these numbers are growing. Within the next two decades, the number of new cancer cases is estimated to rise to 22 million.

This is why Bristol-Myers Squibb has chosen to support the Union for International Cancer Control (UICC) and its members in their mission to reduce the global cancer burden and integrate cancer control into the world health and development agenda.

Encourage your colleagues, families and friends to donate, as cancer affects us all. Each team rides and raises funds for members of the Union for International Cancer Control.

How to support the C2C4C ride

Choose one of the teams - and related cancer organisation(s) - that you want to support and donate to:

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

About the Union for International Cancer Control

The Union for International Cancer Control (UICC) is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite the cancer community to reduce the global cancer burden, promote greater equity, and integrate cancer control into the world health and development agenda.

Founded in 1933 and based in Geneva, Switzerland, the Union for International Cancer Control is the largest and oldest international cancer organisation. With over 1,000 members and 56 partners across 162 countries, the Union for International Cancer Control features the world’s major cancer societies, ministries of health, research institutes, patient groups, and industry leaders.

Activity highlights See all92
Follow this campaign to receive updates by email.
Recent contributions